The University of Chicago Header Logo

Search Results (99)

Abnormalities of chromosome 1 in myeloproliferative disorders.Academic Article Why?
Hematopathologic findings in the myeloproliferative disorders.Academic Article Why?
Pulmonary arterial hypertension and myeloproliferative disorders.Academic Article Why?
Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.Academic Article Why?
Combined plateletpheresis and cytotoxic chemotherapy for symptomatic thrombocytosis in myeloproliferative disorders.Academic Article Why?
Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.Academic Article Why?
The diagnostic interface between histology and molecular tests in myeloproliferative disorders.Academic Article Why?
The molecular biology of myeloproliferative disorders as revealed by chromosomal abnormalities.Academic Article Why?
Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes.Academic Article Why?
Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7.Academic Article Why?
A new family with a germline ANKRD26 mutation and predisposition to myeloid malignancies.Academic Article Why?
A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia.Academic Article Why?
AKT is a therapeutic target in myeloproliferative neoplasms.Academic Article Why?
Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.Academic Article Why?
Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach.Academic Article Why?
Per Page    Page  of 7last Nextnext
Search Criteria
  • Myeloproliferative Disorders
Filter by Type
Click "Why?" to see why an item matched the search.